Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions of single cells, creating detailed maps of tissues, organs, and diseases.
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results